About 8 results found for searched term "143-57-7" (0.063 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M6675 | Diprenorphine | Others |
| Diprenorphine is a non-selective opioid antagonist. | ||
| M28430 | Lometrexol hydrate | Antifolate |
| DDATHF hydrate | ||
| Lometrexol (DDATHF) hydrate, an antipurine antifolate, can inhibit the activity of glycinamide ribonucleotide formyltransferase (GARFT) but do not induce detectable levels of DNA strand breaks. Lometrexol hydrate can further inhibit de novo purine synthesis, causing abnormal cell proliferation and apoptosis, even cell cycle arrest. Lometrexol hydrate has anticancer activity. Lometrexol hydrate also is a potent human Serine hydroxymethyltransferase1/2 (hSHMT1/2) inhibitor. | ||
| M40267 | Protoveratrine A | Others |
| Protoveratrine A (NSC 7526; Protalba; Protoveratrin) is an alkaloid with strong cardiostimulant and vasoconstrictive effects, which can be used in the study of hypertension and other cardiovascular diseases. | ||
| M51328 | CD36 Peptide P (93-110), Cys conjugated | Others |
| CD36 Peptide P (93-110), Cys conjugated is a Cys labelled CD36 Peptide, and can block binding of CD36 to immobilized thrombospondin and partially inhibited collagen-induced platelet aggregation. | ||
| M51333 | CD36 Peptide P (139-155), Cys conjugated | Others |
| CD36 Peptide P (139-155), Cys conjugated is a Cys labelled CD36 Peptide, and can inhibit the immunoadsorption of CD36 by OKM5. | ||
| M52642 | FTISADTSK | Metabolite/Endogenous Metabolite |
| FTISADTSK is an endogenous stable signature peptide from Trastuzumab monitored by selected reaction monitoring (SRM). | ||
| M52645 | IYPTNGYTR | Metabolite/Endogenous Metabolite |
| IYPTNGYTR, a deamidation-sensitive signature peptide, is a deamidation product of Trastuzumab. | ||
| M54247 | WKYMVM-NH2 TFA | FPR |
| WKYMVM-NH2 TFA is a potent N-formyl peptide receptor (FPR1) and FPRL1/2 agonist, also activates several leukocyte effector functions. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
